The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study

(2021) Partha Basu et al.   LANCET ONCOLOGY

More evidence suggesting that 1‐dose human papillomavirus vaccination may be effective

(2020) Julia M. L. Brotherton et al.   CANCER

Comparison of the long‐term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study

(2020) Ana M. Rodriguez et al.   CANCER

Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial

(2020) Aimée R Kreimer et al.   JNCI-Journal of the National Cancer Institute

HPV Vaccination and the Risk of Invasive Cervical Cancer

(2020) Jiayao Lei et al.   NEW ENGLAND JOURNAL OF MEDICINE

Data Resource Profile: National Cancer Registration Dataset in England

(2019) Katherine E Henson et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

(2019) Mélanie Drolet et al.   LANCET

Vaccination protects against invasive HPV-associated cancers

(2018) Tapio Luostarinen et al.   INTERNATIONAL JOURNAL OF CANCER

The Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010–2016

(2018) David Mesher et al.   JOURNAL OF INFECTIOUS DISEASES

Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?

(2018) Alejandra Castanon et al.   PREVENTIVE MEDICINE

Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies

(2018) Aimée R. Kreimer et al.   VACCINE

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

(2016) Rengaswamy Sankaranarayanan et al.   LANCET ONCOLOGY

Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation

(2014) David Mesher et al.   JOURNAL OF CLINICAL PATHOLOGY

The impact of Jade Goody's diagnosis and death on the NHS Cervical Screening Programme

(2012) L Lancucki et al.   JOURNAL OF MEDICAL SCREENING

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK

(2010) J Cuzick et al.   BRITISH JOURNAL OF CANCER